» Articles » PMID: 23638368

Associations Between the Human Intestinal Microbiota, Lactobacillus Rhamnosus GG and Serum Lipids Indicated by Integrated Analysis of High-throughput Profiling Data

Overview
Journal PeerJ
Date 2013 May 3
PMID 23638368
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence indicates that the intestinal microbiota regulates our physiology and metabolism. Bacteria marketed as probiotics confer health benefits that may arise from their ability to affect the microbiota. Here high-throughput screening of the intestinal microbiota was carried out and integrated with serum lipidomic profiling data to study the impact of probiotic intervention on the intestinal ecosystem, and to explore the associations between the intestinal bacteria and serum lipids. We performed a comprehensive intestinal microbiota analysis using a phylogenetic microarray before and after Lactobacillus rhamnosus GG intervention. While a specific increase in the L. rhamnosus-related bacteria was observed during the intervention, no other changes in the composition or stability of the microbiota were detected. After the intervention, lactobacilli returned to their initial levels. As previously reported, also the serum lipid profiles remained unaltered during the intervention. Based on a high-resolution microbiota analysis, intake of L. rhamnosus GG did not modify the composition of the intestinal ecosystem in healthy adults, indicating that probiotics confer their health effects by other mechanisms. The most prevailing association between the gut microbiota and lipid profiles was a strong positive correlation between uncultured phylotypes of Ruminococcus gnavus-group and polyunsaturated serum triglycerides of dietary origin. Moreover, a positive correlation was detected between serum cholesterol and Collinsella (Coriobacteriaceae). These associations identified with the spectrometric lipidome profiling were corroborated by enzymatically determined cholesterol and triglyceride levels. Actinomycetaceae correlated negatively with triglycerides of highly unsaturated fatty acids while a set of Proteobacteria showed negative correlation with ether phosphatidylcholines. Our results suggest that several members of the Firmicutes, Actinobacteria and Proteobacteria may be involved in the metabolism of dietary and endogenous lipids, and provide a scientific rationale for further human studies to explore the role of intestinal microbes in host lipid metabolism.

Citing Articles

Sugar Composition of Thai Desserts and Their Impact on the Gut Microbiome in Healthy Volunteers: A Randomized Controlled Trial.

Senaprom S, Namjud N, Ondee T, Bumrungpert A, Pongpirul K Nutrients. 2024; 16(22).

PMID: 39599719 PMC: 11597037. DOI: 10.3390/nu16223933.


Altered Gut Microbiome Composition in Dogs with Hyperadrenocorticism: Key Bacterial Genera Analysis.

Kang H, Kim S, Kim S, La T, Hyun J, Lee S Animals (Basel). 2024; 14(19).

PMID: 39409832 PMC: 11476382. DOI: 10.3390/ani14192883.


Sex-specific alterations in the gut and lung microbiome of allergen-induced mice.

Ekpruke C, Alford R, Rousselle D, Babayev M, Sharma S, Parker E Front Allergy. 2024; 5:1451846.

PMID: 39210977 PMC: 11358121. DOI: 10.3389/falgy.2024.1451846.


Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.

Elbere I, Orlovskis Z, Ansone L, Silamikelis I, Jagare L, Birzniece L Gut Microbes. 2024; 16(1):2361491.

PMID: 38868903 PMC: 11178274. DOI: 10.1080/19490976.2024.2361491.


Probiotics combined with atorvastatin administration in the treatment of hyperlipidemia: A randomized, double-blind, placebo-controlled clinical trial.

Tian Y, Wu G, Zhao X, Zhang H, Ren M, Song X Medicine (Baltimore). 2024; 103(21):e37883.

PMID: 38788020 PMC: 11124713. DOI: 10.1097/MD.0000000000037883.


References
1.
Le Cao K, Gonzalez I, Dejean S . integrOmics: an R package to unravel relationships between two omics datasets. Bioinformatics. 2009; 25(21):2855-6. PMC: 2781751. DOI: 10.1093/bioinformatics/btp515. View

2.
Rajilic-Stojanovic M, Biagi E, Heilig H, Kajander K, Kekkonen R, Tims S . Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011; 141(5):1792-801. DOI: 10.1053/j.gastro.2011.07.043. View

3.
Blaut M, Clavel T . Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr. 2007; 137(3 Suppl 2):751S-5S. DOI: 10.1093/jn/137.3.751S. View

4.
Lecerf J, de Lorgeril M . Dietary cholesterol: from physiology to cardiovascular risk. Br J Nutr. 2011; 106(1):6-14. DOI: 10.1017/S0007114511000237. View

5.
Parmigiani G, Garrett-Mayer E, Anbazhagan R, Gabrielson E . A cross-study comparison of gene expression studies for the molecular classification of lung cancer. Clin Cancer Res. 2004; 10(9):2922-7. DOI: 10.1158/1078-0432.ccr-03-0490. View